Philadelphia, PA | October 2022 – RatnerPrestia’s James Matthew Gould will be presenting an interactive case study in the pharmaceutical patent space on October 18, 2022, in Munich, Germany at C5’s 20th Anniversary Life Sciences IP Summit. His topic will focus on allegations of patent infringement when generic companies carve out patented indications from their label. More details here: https://www.c5-online.com/life-sciences-ip-summit/.
RatnerPrestia is a law firm expert in all things IP. The Firm handles procurement, enforcement, licensing, commercialization, global strategic IP planning, and all related business aspects of IP. The Firm has attorneys experienced and successful in all relevant U.S. jurisdictions, including the U.S. Patent and Trademark Office, The U.S. International Trade Commission and Federal Courts, both trial and appellate. This expertise extends to all areas of IP protection, including patent, design, copyright, software, trademark, and trade secret protection.